vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Gen Digital (GEN). Click either name above to swap in a different company.

Gen Digital is the larger business by last-quarter revenue ($1.2B vs $749.2M, roughly 1.7× CLOVER HEALTH INVESTMENTS, CORP.). Gen Digital runs the higher net margin — 15.5% vs 3.6%, a 11.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 28.5%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 13.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Gen Digital Inc. is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.

CLOV vs GEN — Head-to-Head

Bigger by revenue
GEN
GEN
1.7× larger
GEN
$1.2B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+33.5% gap
CLOV
62.0%
28.5%
GEN
Higher net margin
GEN
GEN
11.8% more per $
GEN
15.5%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
13.2%
GEN

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLOV
CLOV
GEN
GEN
Revenue
$749.2M
$1.2B
Net Profit
$27.3M
$192.0M
Gross Margin
78.4%
Operating Margin
3.6%
34.9%
Net Margin
3.6%
15.5%
Revenue YoY
62.0%
28.5%
Net Profit YoY
6.1%
EPS (diluted)
$0.05
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GEN
GEN
Q1 26
$749.2M
$1.2B
Q4 25
$487.7M
$1.2B
Q3 25
$496.6M
$1.3B
Q2 25
$477.6M
Q1 25
$462.3M
$1.0B
Q4 24
$337.0M
$986.0M
Q3 24
$331.0M
$974.0M
Q2 24
$356.3M
$965.0M
Net Profit
CLOV
CLOV
GEN
GEN
Q1 26
$27.3M
$192.0M
Q4 25
$-49.3M
$134.0M
Q3 25
$-24.4M
$135.0M
Q2 25
$-10.6M
Q1 25
$-1.3M
$142.0M
Q4 24
$-22.1M
$159.0M
Q3 24
$-9.2M
$161.0M
Q2 24
$7.4M
$181.0M
Gross Margin
CLOV
CLOV
GEN
GEN
Q1 26
78.4%
Q4 25
78.2%
Q3 25
78.8%
Q2 25
Q1 25
80.3%
Q4 24
80.4%
Q3 24
24.5%
80.1%
Q2 24
30.3%
80.3%
Operating Margin
CLOV
CLOV
GEN
GEN
Q1 26
3.6%
34.9%
Q4 25
-10.1%
35.9%
Q3 25
-4.9%
35.5%
Q2 25
-2.2%
Q1 25
-0.3%
41.3%
Q4 24
-6.4%
37.9%
Q3 24
-2.7%
41.3%
Q2 24
2.0%
43.2%
Net Margin
CLOV
CLOV
GEN
GEN
Q1 26
3.6%
15.5%
Q4 25
-10.1%
11.0%
Q3 25
-4.9%
10.7%
Q2 25
-2.2%
Q1 25
-0.3%
14.1%
Q4 24
-6.6%
16.1%
Q3 24
-2.8%
16.5%
Q2 24
2.1%
18.8%
EPS (diluted)
CLOV
CLOV
GEN
GEN
Q1 26
$0.05
$0.31
Q4 25
$0.21
Q3 25
$0.22
Q2 25
Q1 25
$0.22
Q4 24
$0.26
Q3 24
$0.26
Q2 24
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GEN
GEN
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
$8.4B
Stockholders' EquityBook value
$339.4M
$2.3B
Total Assets
$697.7M
$15.8B
Debt / EquityLower = less leverage
3.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GEN
GEN
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
$1.0B
Q4 24
$194.5M
$883.0M
Q3 24
$288.0M
$737.0M
Q2 24
$254.8M
$644.0M
Total Debt
CLOV
CLOV
GEN
GEN
Q1 26
$8.4B
Q4 25
$8.7B
Q3 25
$8.9B
Q2 25
Q1 25
$8.3B
Q4 24
$8.5B
Q3 24
$8.5B
Q2 24
$8.5B
Stockholders' Equity
CLOV
CLOV
GEN
GEN
Q1 26
$339.4M
$2.3B
Q4 25
$308.7M
$2.5B
Q3 25
$340.9M
$2.4B
Q2 25
$344.2M
Q1 25
$336.1M
$2.3B
Q4 24
$341.1M
$2.2B
Q3 24
$342.2M
$2.1B
Q2 24
$324.9M
$2.0B
Total Assets
CLOV
CLOV
GEN
GEN
Q1 26
$697.7M
$15.8B
Q4 25
$541.0M
$16.1B
Q3 25
$559.7M
$16.4B
Q2 25
$575.0M
Q1 25
$583.7M
$15.5B
Q4 24
$580.7M
$15.4B
Q3 24
$653.0M
$15.5B
Q2 24
$674.2M
$15.4B
Debt / Equity
CLOV
CLOV
GEN
GEN
Q1 26
3.61×
Q4 25
3.54×
Q3 25
3.75×
Q2 25
Q1 25
3.64×
Q4 24
3.94×
Q3 24
4.06×
Q2 24
4.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GEN
GEN

Cyber Safety Platform$819.0M66%
Trust Based Solutions$421.0M34%
Net Interest Income On Notes Receivable$4.0M0%

Related Comparisons